Functional characterization and inhibition of the type II DNA topoisomerase coded by African swine fever virus

Virology. 2016 Jun:493:209-16. doi: 10.1016/j.virol.2016.03.023. Epub 2016 Apr 6.

Abstract

DNA topoisomerases are essential for DNA metabolism and while their role is well studied in prokaryotes and eukaryotes, it is less known for virally-encoded topoisomerases. African swine fever virus (ASFV) is a nucleo-cytoplasmic large DNA virus that infects Ornithodoros ticks and all members of the family Suidae, representing a global threat for pig husbandry with no effective vaccine nor treatment. It was recently demonstrated that ASFV codes for a type II topoisomerase, highlighting a possible target for control of the virus. In this work, the ASFV DNA topoisomerase II was expressed in Saccharomyces cerevisiae and found to efficiently decatenate kDNA and to processively relax supercoiled DNA. Optimal conditions for its activity were determined and its sensitivity to a panel of topoisomerase poisons and inhibitors was evaluated. Overall, our results provide new knowledge on viral topoisomerases and on ASFV, as well as a possible target for the control of this virus.

Keywords: ASFV; African swine fever virus; Amsacrine; Ciprofloxacin; DNA Topoisomerases, Type II; Doxorubicin; P1192R; Topoisomerase II inhibitors.

MeSH terms

  • African Swine Fever Virus / enzymology*
  • African Swine Fever Virus / genetics
  • Aminocoumarins / pharmacology
  • Amsacrine / pharmacology
  • Crithidia fasciculata / genetics
  • DNA Topoisomerases, Type II / genetics*
  • Doxorubicin / pharmacology
  • Saccharomyces cerevisiae / genetics
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Aminocoumarins
  • Topoisomerase II Inhibitors
  • Amsacrine
  • Doxorubicin
  • DNA Topoisomerases, Type II
  • coumermycin